IHAM
RGEN icon

Integral Health Asset Management’s Repligen RGEN Stock Holding History

Integral Health Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,000
Closed -$2.54M – 96
2025
Q1 		$2.54M Sell
20,000
-20,000
-50% -$3.08M 0.27% 70
2024
Q4 		$5.76M Buy
+40,000
New +$5.74M 0.49% 59
2024
Q3 		– Sell
-60,000
Closed -$7.56M – 92
2024
Q2 		$7.56M Buy
60,000
+10,000
+20% +$1.57M 0.72% 44
2024
Q1 		$9.2M Sell
50,000
-5,000
-9% -$952K 0.85% 46
2023
Q4 		$9.89M Buy
+55,000
New +$8.56M 1.35% 32

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Integral Health Asset Management's RGEN Position: Q2 2025 in Review

Integral Health Asset Management sold out of Repligen (RGEN) in Q2 2025, closing a stake of 20,000 shares — an estimated $2.54M sold.

Integral Health Asset Management first reported a position in RGEN in Q4 2023 and held it in 5 quarters. The position peaked at $9.89M in Q4 2023. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

  • Integral Health Asset Management reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
  • Integral Health Asset Management sold 20,000 Repligen shares in Q2 2025, an estimated $2.54M.
  • Integral Health Asset Management first reported a position in Repligen in Q4 2023 and held it in 5 quarters.
  • Integral Health Asset Management's Repligen position peaked at $9.89M in Q4 2023.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Integral Health Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.